LONDON and NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech (Claritas) a leader in medical image enhancement and AI diagnostic software solutions, is pleased to announce it has established Intelligent Scopes Corp (ISC), a USA headquartered company to focus on the long-term research and development, and delivery of its endoscopic image processing and AI-assisted diagnostic solutions for urology and gastroenterology.

伦敦和纽约，2023年11月3日（GLOBE NEWSWIRE）-医学图像增强和AI诊断软件解决方案的领导者Claritas HealthTech（Claritas）很高兴宣布成立了Intelligent Scopes Corp（ISC），这是一家美国总部公司专注于长期研发，并提供其内窥镜图像处理和AI辅助泌尿外科和胃肠病学诊断解决方案。

Claritas, headquartered in London, specializes in developing cutting-edge image processing, image enhancement and AI diagnostic tools across various modalities ranging from radiology and nuclear medicine to dermatology and ophthalmology. Over the past two years, the company has developed pioneering technology for precision AI detection of conditions in endoscopic and cystoscopic images.

Claritas总部设在伦敦，专门从事开发尖端图像处理，图像增强和AI诊断工具，涵盖从放射学和核医学到皮肤病学和眼科学等各种形式。在过去两年中，该公司开发了用于内窥镜和膀胱镜图像中条件的精确AI检测的开创性技术。

Chetan Baxi, CEO of Claritas commented, “With the establishment of Intelligent Scopes Corp, we will be able to strengthen our strategic focus and capitalize on growth opportunities. This will enable us to accelerate the development of platforms that support AI diagnostic tools and image enhancement solutions for clinicians and to aid image-guided robotic surgical procedures.” These technologies aim to advance diagnostic pathways in some of the most common cancers.

Claritas首席执行官Chetan Baxi评论说：“随着Intelligent Scopes Corp的成立，我们将能够加强战略重点并利用增长机会。这将使我们能够加速支持AI诊断工具和图像的平台的开发。为临床医生提供增强解决方案，并帮助图像引导的机器人外科手术。“这些技术旨在推进一些最常见癌症的诊断途径。

Worldwide, colon cancer ranks as the 3rd most common cancer; bladder cancer is the 10th most common cancer, and the 6th most common in men. Diagnostics (using endoscopes for the bowel and cystoscopes for the bladder) are challenging, and time and resource intensive. There is an immediate need for streamlined and automated tools to economize and improve detection and surveillance of these diseases.

在世界范围内，结肠癌被列为第三大常见癌症；膀胱癌是第十大常见癌症，也是男性中第六大常见癌症。诊断（使用内窥镜进行肠道和膀胱镜检查）具有挑战性，并且需要大量时间和资源。迫切需要简化和自动化的工具来节省和改进对这些疾病的检测和监测。

Dr. Rajesh Nair, incoming CEO of Intelligent Scopes Corp commented, “I am excited to be heading up a tea.

Intelligent Scopes Corp的首席执行官Rajesh Nair博士评论说：“我很高兴能够喝茶。